Cargando…
Characterizing health plan evidence review practices
BACKGROUND: Health plans guide enrollees’ access to specialty drugs through coverage policies. Practice guidelines recommend that the evidence supporting drug coverage policies should be comprehensive and routinely updated to reflect evidence-based medicine. OBJECTIVE: To examine the frequency with...
Autores principales: | Panzer, Ari D, Enright, Daniel E, Graff, Jen, Chambers, James D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373012/ https://www.ncbi.nlm.nih.gov/pubmed/36001106 http://dx.doi.org/10.18553/jmcp.2022.28.9.1053 |
Ejemplares similares
-
Use of prescriber requirements among US commercial health plans
por: Lenahan, Kelly, et al.
Publicado: (2021) -
Examining US commercial health plans’ use of The Institute for Clinical and Economic Review’s reports in specialty drug coverage decisions
por: Chambers, James D, et al.
Publicado: (2023) -
The association between US Food and Drug Administration−expedited review designations and health plan specialty drug coverage
por: Panzer, Ari D, et al.
Publicado: (2023) -
Variation in health plan specialty drug coverage: an empirical analysis
por: Margaretos, Nikoletta M., et al.
Publicado: (2019) -
Limited role of patient input in specialty drug coverage policies
por: D’Cruz, Brittany, et al.
Publicado: (2021)